NEW YORK, July 25, 2018 /PRNewswire/ --
A report by Energias Market Research predicts that the global medical cannabis market will grow significantly, from
USD 8.28 Billion in 2017 to USD 28.07 Billion in 2024 and at a CAGR
of 19.1% from 2018 to 2024. Factors influencing the medicinal cannabis industry include the growing acknowledgment of medicinal
benefits, stronger demand for cannabis in the treatment of various diseases and a rising number of research and development
activities. Sales of cannabis products for recreational (adult use) use are also expected to increase, as California's new recreational cannabis laws went into effect on January 1st,
2018. CLS Holdings USA Inc. (OTC: CLSH), Innovative Industrial Properties Inc. (NYSE:
IIPR), iAnthus Capital Holdings Inc. (OTC: ITHUF), General Cannabis Corp (OTC: CANN), Cannabis Sativa, Inc. (OTC: CBDS)
Recent legislative victories for the cannabis industry are expected to have a highly positive impact on the economy. "The
cannabis sector currently employs an estimated 125,000 to 160,000 full-time workers," industry analyst and Editorial Vice
President of MJBizDaily, Chris Walsh, explained at The Marijuana Business Conference & Expo,
according to a report from Fortune. "To put this in perspective, there are potentially more full-time marijuana industry workers
than there are librarians or kindergarten teachers throughout the country - and over 6 times the number of coal miners in the
U.S."
CLS Holdings USA Inc. (OTCQB: CLSH) recently announced breaking news that, "an update
to the first complete year of adult use cannabis in Nevada, the first state the Company is
operating in. According to the Nevada Department of Taxation, marijuana flower/bud accounted for roughly 50% of all combined
medical and adult-use marijuana purchases by consumers in Nevada, followed by concentrates at
about 25% and infused edibles at 13%. Oasis Cannabis announced that packaged marijuana flower/bud and pre-rolled joints
represented 67% of the total sales, followed by concentrates at 20% and infused edibles at 9%.
The Co-Founder of Oasis Cannabis, Ben Sillitoe, commented on the sales mix, 'Convenience items
like disposable vapor pens and pre-rolled joints are very popular with our tourist customers and together they make up about 25%
of total sales at Oasis.'
Oasis Cannabis served over 127,000 customers in its 1st year of adult-use sales. About 13% of those orders and 22% of total
sales were to medical patients. The average order from a medical customer was USD 73 whereas a
typical recreational customer spent USD 41 per order. 'A medical patient will typically consume
more cannabis than an average retail customer, so we expect to see larger average purchases from that group,' explained
Sillitoe.
Home deliveries made up 5% of the total orders and 11% of total revenue, reflecting a higher average order of USD 98 versus USD 42 from in-store customers. The average delivery order from a
medical customer was USD 114 and the average delivery to a recreational customer totaled about
USD 87. 'Medical customers make up about 50% of total delivery sales for a couple reasons,'
Sillitoe explained. 'We've been delivering to medical patients since we opened in 2015 so we've had time to build a loyal
customer base in that segment. Medical patients are also more likely to be inconvenienced by a trip to the store because of
various health reasons.'
About Oasis Cannabis (http://oasiscannabis.com ) - Oasis Cannabis has
operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in
Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its
location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination
with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. The Company recently commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products in
August 2017. An expansion of its cultivation and production facility is currently underway and is
expected to be completed during the second half of 2018."
Innovative Industrial Properties Inc. (NYSE: IIPR) is a self-advised Maryland
corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced,
state-licensed operators for their regulated medical-use cannabis facilities. Earlier this month, the Company announced that it
closed on the acquisition of a property located at 96 Palmer Road in Monson, Massachusetts,
which comprises approximately 55,000 sq. ft. of industrial space situated on approximately 5.4 acres. The purchase price for the
property was USD 12.75 Million. Concurrent with the closing of the purchase, the Company entered
into a long-term, triple-net lease agreement with Holistic Industries Inc., which intends to continue to operate the property as
a medical-use cannabis cultivation and processing facility in accordance with Massachusetts
medical-use cannabis regulations. The initial term of the lease is 20 years, with three options to extend the term for three
additional five-year periods.
iAnthus Capital Holdings Inc. (OTCQB: ITHUF) owns and operates best-in-class licensed cannabis cultivation,
processing and dispensary facilities throughout the United States, providing investors
diversified exposure to the U.S. regulated cannabis industry. Recently, the Company announced that its wholly-owned subsidiary,
Citiva Medical, LLC, has begun construction on its 39,500 sq. ft. medical cannabis cultivation and processing facility, located
at the former Mid-Orange State Correctional Facility in the Town of Warwick, New York. Citiva,
one of only ten New York State licensed medical cannabis Registered Organizations, received its
license to operate one cultivation/processing facility and four dispensaries on August 1st, 2017.
The facility will implement high-end technology and cultivation practices to maximize efficiencies and production, including a
positive pressure air system, mobile containers, desiccant dehumidification systems, acrylic glazing, and a unified program for
environmental, irrigation and lighting controls. These state-of-the-art processes will enable perpetual harvesting, with an
estimated yearly production of 2,400 kg of medical cannabis.
General Cannabis Corp (OTCQX: CANN) is the comprehensive national resource for the highest quality service providers
available to the regulated cannabis industry. On May 14, 2018, the Company announced financial
results for the quarter ended March 31, 2018. Robert Frichtel, Chief
Executive Officer of General Cannabis, said: "General Cannabis announced first quarter financial results today. For the first
quarter of 2018, we reported revenues of $942,482, a 31% increase over 2017 first quarter revenues
of $719,105. Our existing operations in Colorado continue to
prosper with Security, Marketing and Operations segments each showing strong year-over-year revenue growth. The team and
infrastructure we have built allows us to scale with the continued expansion within cannabis industry."
Cannabis Sativa, Inc. (OTCQB: CBDS) announced on April 5th that PrestoDoctor®, the
leading online medical marijuana recommendation service, expanded to Pennsylvania on
April 20th, 2018. CBDS licenses the ''hi'' and ''White Rabbit'' brands, holds a U.S. patent on the
Ecuadorian Sativa strain of Cannabis, owns patent pending and trade secret formulas and processes, offers the hi benefits
discount pharmacy card, and operates subsidiaries that include: PrestoDoctor®. ''We are extremely excited to be expanding to
Pennsylvania, and to help patients have easier access in obtaining a medical marijuana card,''
said PrestoDoctor® Co-Founder and CEO, Kyle Powers. ''With so many people looking for an opioid
alternative, and other natural options, it's important to provide an easy, honest, and affordable service,'' he added.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For CLS Holdings USA Inc. financial news
dissemination and PR services, FinancialBuzz.com has been compensated five thousand dollars by the
company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or
site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and
the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in
securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the
information on the editorial or Site or continue to post information about any companies the information contained herein is not
intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation.
The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members
and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site,
company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors
accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation
of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and
website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time.
None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any
particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication
is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment
strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree
to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no
representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change
without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not
guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.
For further information:
Media Contact: info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com